HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesAssetsScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

Emerging Clinical Evidence in Pain Management: SCS and rTMS Therapies

Intelligence briefing

Intelligence Briefing · ~4 min read

Emerging Clinical Evidence in Pain Management: SCS and rTMS Therapies

Neurology · Painful Diabetic Neuropathy

Type

Strategic Briefing

Generated

Jul 23, 2026

Confidence

Moderate Confidence · 72%

Evidence

2 items

Sources

2

Key Takeaways

Leadership-ready summary — read in 4 minutes.

  • Positive results could lead to increased adoption of rTMS in clinical practice, impacting competitors in the pain management space. The strongest clinical anchor is Effects Of Sahrmann's Versus McGill Exercise In Patients With Non-Specific Low Back Pain (ClinicalTrials.gov), weak alignment to signal sub-indication and entities. In pain, 3 regulatory and 0 competitive items passed relevance filtering for rTMS therapy.
  • Monitor the enrollment progress and initial outcome results of Nevro's SCS therapy study, as they may impact competitive standing.
  • Watch for trial results and subsequent publications related to rTMS, which could influence treatment protocols in pain management.

Why It Matters

Strategic context for leadership and portfolio decision-making.

Positive results could lead to increased adoption of rTMS in clinical practice, impacting competitors in the pain management space. The strongest clinical anchor is Effects Of Sahrmann's Versus McGill Exercise In Patients With Non-Specific Low Back Pain (ClinicalTrials.gov), weak alignment to signal sub-indication and entities. In pain, 3 regulatory and 0 competitive items passed relevance filtering for rTMS therapy.

Supporting Evidence

Evidence-backed items from the Humanexa intelligence graph.

  • Nevro Corp. Launches Global Study on SCS Therapy for Painful Diabetic Neuropathy

    Neurology · Painful Diabetic Neuropathy

    Source: Trial Update

    View evidence
  • Study on rTMS Therapy for Neuropathic Pain in Spinal Cord Injury Patients

    Neurology · Pain Management

    Source: Trial Update

    View evidence

Related Intelligence

Deep links to signals, insights, companies, and assets in the Humanexa graph.

Signals

  • Nevro Corp. Launches Global Study on SCS Therapy for Painful Diabetic Neuropathy

    Neurology · Painful Diabetic Neuropathy

  • Study on rTMS Therapy for Neuropathic Pain in Spinal Cord Injury Patients

    Neurology · Pain Management

Insights

  • Emerging Clinical Evidence in Pain Management: SCS and rTMS Therapies

    Neurology · Painful Diabetic Neuropathy

PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.